It has been almost a year since COVID-19 vaccination campaigns commenced and as vaccination coverage increases, vaccine effectiveness data and impact of vaccination are reported from countries across the globe. This symposium intends to share key insights and knowledge from the Pfizer-BioNTech COVID-19 mRNA-vaccine clinical development and roll-out. The focus will be on Israel, being one of the first countries to rapidly increase its vaccine uptake and continuously producing a wealth of outcomes data from integrated health data registries. During this hour we hope to provide further information to support rational and efficient use of the Pfizer-BioNTech COVID-19 mRNA-vaccine.
09.00 – 09.05 Opening remarks, Andreas Palmborg, M.Sc. Medical Lead, Pfizer Vaccines, Sweden
09.05 – 09.25 Clinical Development of the Pfizer-BioNTech COVID-19 mRNA-vaccine, Christian Lenz, MD, PhD, MSc (Pharm Med)
Senior Medical Director Vaccines, Pfizer Vaccines, Germany
09.25 – 09.45 The Israeli COVID-19 vaccination experience, Dr. Einav G. Levin
Infection Prevention and Control Unit, Sheba Medical Center Tel Hashome, Israel
09.45 – 10.00 Questions & Answer